$OMDA News

Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress

Omada Health To Present Published Research Showing That Members Of Its GLP-1 Care Track Lost More Weight And Experienced Greater Improvements In Body Composition Than GLP-1 Users Receiving Usual Care

Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026

Transcript: Omada Health Q2 2026 Earnings Conference Call

Is Omada Health (OMDA) Cheap As Investors Question Its Long Term Targets?

Omada Health Shows Promising Growth But I Question The Moat

Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

Barclays Maintains Overweight on Omada Health, Raises Price Target to $27

Needham Reiterates Buy on Omada Health, Maintains $28 Price Target

BTIG Reiterates Buy on Omada Health, Maintains $35 Price Target

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program

Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

Omada Health (NASDAQ:OMDA) Combines High Growth Momentum with Breakout Setup

JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30

Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Baird Maintains Neutral on Omada Health, Raises Price Target to $25

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy